Related references
Note: Only part of the references are listed.miR-335 Represents an Independent Prognostic Marker in Epithelial Ovarian Cancer
Jin Cao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
HE4 as a Serum Biomarker for ROMA Prediction and Prognosis of Epithelial Ovarian Cancer
Wen-Ting Chen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
Y. Xue et al.
BRITISH JOURNAL OF CANCER (2014)
DNA Damage Triggers Golgi Dispersal via DNA-PK and GOLPH3
Suzette E. Farber-Katz et al.
CELL (2014)
RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
Katia Y. Caceres-Gorriti et al.
PLOS ONE (2014)
Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis
Yan Wang et al.
TUMOR BIOLOGY (2014)
High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma
Yingchun Ma et al.
VIRCHOWS ARCHIV (2014)
GOLPH3 Is Essential for Contractile Ring Formation and Rab11 Localization to the Cleavage Site during Cytokinesis in Drosophila melanogaster
Stefano Sechi et al.
PLOS GENETICS (2014)
TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
T. Liu et al.
BRITISH JOURNAL OF CANCER (2013)
The Drosophila GOLPH3 homolog regulates the biosynthesis of heparan sulfate proteoglycans by modulating the retrograde trafficking of exostosins
Wei-Ling Chang et al.
DEVELOPMENT (2013)
Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies
Jung-Yun Lee et al.
GYNECOLOGIC ONCOLOGY (2013)
Functional Characterization of Human Myosin-18A and Its Interaction with F-actin and GOLPH3
Manuel H. Taft et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer
Ben-Shun Hu et al.
TUMOR BIOLOGY (2013)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination
Xiao-Jiang Wu et al.
TUMOR BIOLOGY (2013)
Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor
Zhaolei Zeng et al.
CLINICAL CANCER RESEARCH (2012)
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
Xing Hua et al.
DIAGNOSTIC PATHOLOGY (2012)
Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis
Jinxu Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
Huan Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer
Min-Bin Chen et al.
PLOS ONE (2012)
The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines
Wolfgang Glienke et al.
TUMOR BIOLOGY (2012)
Tumor immune surveillance and ovarian cancer Lessons on immune mediated tumor rejection or tolerance
Lana E. Kandalaft et al.
CANCER AND METASTASIS REVIEWS (2011)
Evolution of platinum resistance in high-grade serous ovarian cancer
Susanna L. Cooke et al.
LANCET ONCOLOGY (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3-Mediated Oncogenesis
Kenneth L. Scott et al.
CLINICAL CANCER RESEARCH (2010)
Ovarian cancer: the duplicity of CA125 measurement
Amer K. Karam et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
Vathany Kulasingam et al.
NATURE REVIEWS CANCER (2010)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
GOLPH3 Bridges Phosphatidylinositol-4-Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding
Holly C. Dippold et al.
CELL (2009)
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
Kenneth L. Scott et al.
NATURE (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
